PD-L1

Open Access
Correlation of HLA-A and HLA-B/C Expression With PD-1 and PD-L1 Expression in Patients With Metastatic Breast Cancer as a Potential Prognosticator of Favorable Survival
LUKAS GOERDT, ALEKSANDRA STEFANOVIC, RALPH WIRTZ, UROS KARIC, MAXIMILIAN KOHLER, THOMAS M. DEUTSCH, ANDREAS SCHNEEWEISS, MARC SÜTTERLIN, STEFAN STEFANOVIC, JAN HOFMANN and MARKUS WALLWIENER

In Vivo March 2025, 39 (2) 758-765; DOI: https://doi.org/10.21873/invivo.13880
Open Access
PD-L1 Expression and Ultrasound Characteristics in Papillary Thyroid Carcinoma and Its Effect on Recurrence
RUI LI, MONONG LI, BIN SUN, MIN QI, CUI PENG, HUI LI, SHUAI ZHENG, QINGWEI LIU and CHANGQING JIANG

In Vivo November 2023, 37 (6) 2820-2828; DOI: https://doi.org/10.21873/invivo.13396
Open Access
Expression and Prognostic Significance of PD-L1 and NY-ESO1 in Gallbladder Carcinoma
AMIR IBUKIĆ, SNJEŽANA RAMIĆ, MARIO ZOVAK, ZDENKO BILIĆ, DAVOR TOMAS and ALMA DEMIROVIĆ

In Vivo July 2023, 37 (4) 1828-1837; DOI: https://doi.org/10.21873/invivo.13274
Open Access
Expression of Three Clones of PD-L1 in Lung Cancer: A Single-center Experience
SANG-GON PARK, HEE JEONG LEE, SEUL BI LEE and RAN HONG

In Vivo January 2023, 37 (1) 233-241; DOI: https://doi.org/10.21873/invivo.13072
You have access
Response to Neoadjuvant Chemotherapy in Locally Advanced Cervical Cancer: The Role of Immune-related Factors
INNOCENZA PALAIA, FEDERICA TOMAO, ANNA DI PINTO, ANGELINA PERNAZZA, GIUSI SANTANGELO, NICOLETTA D’ALESSANDRIS, LUCIA MANGANARO, ANTONIO ARNO, VIOLANTE DI DONATO, GIORGIA PERNIOLA, CARLO DELLA ROCCA and PIERLUIGI BENEDETTI PANICI

In Vivo March 2021, 35 (2) 1277-1283; DOI: https://doi.org/10.21873/invivo.12379
You have access
Clinical Significance of Tumor and Immune Cell PD-L1 Expression in Gastric Adenocarcinoma
DONG HYUN KIM, GO EUN BAE, KWANG SUN SUH, DAVID RYUMAN, KYU SANG SONG, JU SEOK KIM, SANG-IL LEE and MIN-KYUNG YEO

In Vivo November 2020, 34 (6) 3171-3180; DOI: https://doi.org/10.21873/invivo.12152
You have access
Genomic Profiling and Clinicopathological Characteristics of Neuroendocrine Tumors of the Lung in East Asian Patients
MOONSIK KIM, YEON SEUNG CHUNG, KYOUNG A KIM and HYO SUP SHIM

In Vivo November 2020, 34 (6) 3375-3385; DOI: https://doi.org/10.21873/invivo.12176
You have access
VEGF-A Is Associated With the Degree of TILs and PD-L1 Expression in Primary Breast Cancer
TAKAAKI FUJII, TOMOKO HIRAKATA, SASAGU KUROZUMI, SHOKO TOKUDA, YUKO NAKAZAWA, SAYAKA OBAYASHI, REINA YAJIMA, TETSUNARI OYAMA and KEN SHIRABE

In Vivo September 2020, 34 (5) 2641-2646; DOI: https://doi.org/10.21873/invivo.12082
You have access
Efficacy of Axitinib After Nivolumab Failure in Metastatic Renal Cell Carcinoma
HIROKI ISHIHARA, TOSHIO TAKAGI, TSUNENORI KONDO, HIRONORI FUKUDA, HIDEKAZU TACHIBANA, KAZUHIKO YOSHIDA, JUNPEI IIZUKA, MASAYOSHI OKUMI, HIDEKI ISHIDA and KAZUNARI TANABE

In Vivo May 2020, 34 (3) 1541-1546; DOI: https://doi.org/10.21873/invivo.11943
You have access
PD-L1 Expression and Tumor-infiltrating Lymphocytes in Breast Cancer: Clinicopathological Analysis in Women Younger than 40 Years Old
ZOI EVANGELOU, ALEXANDRA PAPOUDOU-BAI, GEORGIA KARPATHIOU, HELEN KOUREA, SEVASTI KAMINA, ANNA GOUSSIA, HARALAMBOS HARISSIS, DIMITRIOS PESCHOS and ANNA BATISTATOU

In Vivo March 2020, 34 (2) 639-647; DOI: https://doi.org/10.21873/invivo.11818

Main menu

User menu

Search

PD-L1

Pages